Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Ali Bazarbachi; Christoph Schmid; Myriam Labopin; Dietrich Beelen; Igor Wolfgang Blau; Victoria Potter; Riitta Niittyvuopio; Gerard Socié; Didier Blaise; Jaime Sanz; Fabio Ciceri; Iman Abou Dalle; Alexandros Spyridonidis; Gesine Bug; Jordi Esteve; Bipin Savani; Arnon Nagler; Mohamad Mohty

doi:10.1158/1078-0432.CCR-20-3134

Journal articles

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Ali Bazarbachi Christoph Schmid Myriam Labopin Dietrich Beelen Igor Wolfgang Blau Victoria Potter Riitta Niittyvuopio Gerard Socié Didier Blaise ¹ Jaime Sanz Fabio Ciceri Iman Abou Dalle Alexandros Spyridonidis Gesine Bug Jordi Esteve Bipin Savani Arnon Nagler Mohamad Mohty

1 CRCM - Centre de Recherche en Cancérologie de Marseille

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03152852
Contributor : Jacques Nunès Connect in order to contact the contributor
Submitted on : Thursday, February 25, 2021 - 8:33:57 PM
Last modification on : Wednesday, November 3, 2021 - 4:42:08 AM

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Links full text

Identifiers

Collections

Citation

Export

Metrics

20

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

20